Options Brief: PharmAthene, Inc.

Shares of PharmAthene, Inc. PIP are lower on the session by 3.62%, trading at $2.66. Overall call volume is now running at 7.41x the daily average, with 3% of all calls traded being purchases on the offer. 4,152 contracts have traded on the session so far. PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons.